The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Lotz Christopher L. since 2021.
This trader's CIK number is 1812553.
At the time of last reporting, Lotz Christopher L. was the Vice President of Finance, CFO of Qualigen Therapeutics, Inc.. (stock ticker symbol QLGN).
Also see all insider trading activities at Qualigen Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | QLGN | 2,700 | $5,022 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-04-16 | QLGN | Buy | 2,700 | 1.86 | 5,022 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lotz Christopher L. (Vice President of Finance, CFO of Qualigen Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.